slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 1,561-1,590
Pages 885
Rows per page 30
Arc
1,561-1,590 of 26,550
10
The slide highlights specific AI products developed by Doximity to address physician burnout.Doximity | Investor Day Presentation Deck | 56 slides · Doximity
Conference presentation Investor relations Beat · Problem (Identify pain)2 hits
09
The chart uses a horizontal bar format to represent development stages, with one program highlighted in orange.Exscientia | Investor Presentation Deck | 45 slides · Exscientia
Conference presentation Investor relations Beat · Solution2 hits
04
Includes a progress bar at the bottom indicating 'Intro' section.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
05
The slide uses a list of key benefits to summarize the product's market and clinical position.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction2 hits
13
Includes a bar chart of motor performance and visual evidence of motor neuron recovery.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
14
Includes a progress bar at the bottom indicating the current section is 'Phase 2a Results'.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
15
The slide uses a comparative clinical trial analysis against a historical control database (PRO-ACT).NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
16
Includes a process diagram showing exosome extraction from blood samples.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
17
Data shows p-values of 0.005 and <0.001 for treated groups, indicating significant biomarker reduction.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
18
The slide uses a process-flow diagram to link trial results to the next phase of development.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
19
Includes a progress bar at the bottom indicating the current stage is Phase 2b.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
20
The slide uses a numbered list format to categorize four distinct patent filings.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
21
The slide uses a logo-grid layout to establish credibility through institutional and industry partnerships.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
22
The slide uses a color-coded legend for ALS, Alzheimer's, and Parkinson's.NeuroSense Therapeutics | Investor Presentation Deck | 34 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
20
The illustration uses a metaphor of Spartan-like figures guarding a treasure chest, likely representing the activist's role in protecting shareholder capital.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Logic Chain2 hits
21
Sarissa Capital | Activist Presentation Deck | 95 slidesSarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose Contradiction2 hits
22
Uses a cartoon character to mock the company's financial performance.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose Contradiction2 hits
23
Uses a 'House That Pops Built' illustration to visually represent the company as unstable or poorly constructed.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose Contradiction2 hits
24
The table highlights the financial dependency on specific royalty streams and their respective patent cliffs.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose Contradiction2 hits
25
Uses a cartoon illustration to emphasize the 'easy money' narrative.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose Contradiction2 hits
26
The slide argues that royalty revenue is essentially pure profit, contrasting it with the company's overall spending.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose Contradiction2 hits
27
Sarissa Capital | Activist Presentation Deck | 95 slidesSarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose Contradiction2 hits
28
The chart uses a red arrow to visually emphasize the growth trend.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose Contradiction2 hits
29
The slide uses a callout to explain why the S&M percentage is calculated against commercial revenues rather than total revenues.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose Contradiction2 hits
30
Uses a map-based visual to represent the scale of the target population relative to the company's reach.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Analogy2 hits
31
The chart uses red arrows to emphasize the valuation gap between Alkermes and larger peers.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Analogy2 hits
32
Uses a visual metaphor of paper bags containing pills to represent sales force efficiency.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Analogy2 hits
33
Uses red underlining to highlight key phrases in quotes; uses a callout box to synthesize the contradiction.Sarissa Capital | Activist Presentation Deck | 95 slides · Sarissa Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Analogy2 hits
04
Theravance Biopharma | Results Presentation Deck | 41 slidesTheravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Attention2 hits
14
The slide outlines a clinical trial methodology including randomization, treatment duration, and primary/secondary endpoints.Theravance Biopharma | Results Presentation Deck | 41 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Before-After2 hits